Sponsored by

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 576 to 600 of about 5880

Previous 25

Website Changes

12/11/2021

Efficacy, Outcome, and Safety of Elderly Patients with Glioblastoma in the 5-ALA Era: Single Center Experience of More Than 10 Years

12/11/2021

Nivolumab for Patients With MGMT Promoter Methylated Glioblastoma

12/11/2021

xDECIDE platform product introduction for brain tumor (and other cancer) doctors.

12/09/2021

A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent Glioblastoma

12/07/2021

The meningioma surface factor: a novel approach to quantify shape irregularity on preoperative imaging and its correlation with WHO grade

12/03/2021

Temporal Trends in Glioblastoma Survival: Progress then Plateau

12/03/2021

VBI Vaccines Reveals Updated Overall Survival Data From Brain Cancer Vaccine Trial

11/25/2021

Targeted Drug Combo Shows Unprecedented Activity in Some Aggressive Brain Tumors

11/24/2021

XCELSIOR - A real time, real world learning platform for patients with advanced cancer

11/24/2021

France allows experimental brain cancer treatment free of charge

11/24/2021

Using Virtual Trials to Screen for Potential Glioblastoma Therapies

11/24/2021

Musella Foundation 2021 Highlights and End of Year Appeal!

11/22/2021

Reproducibility of clinical trials using CMV-targeted dendritic cell vaccines in patients with glioblastoma

11/22/2021

Safety and efficacy of PVSRIPO in recurrent glioblastoma: long-term follow-up and initial multicenter results

11/22/2021

Plus Therapeutics Announces Positive Interim Data from ReSPECT™-GBM Phase 1 Clinical Trial at the 2021 Society for Neuro-Oncology Annual Meeting

11/22/2021

First experience with maximal safe resection and Gammatile brachytherapy as treatment for recurrent glioblastoma

11/22/2021

Chimerix Announces Positive ONC201 Data in Recurrent H3 K27M-mutant Diffuse Midline Glioma to Be Presented at the Society for Neuro-Oncology Annual Meeting

11/22/2021

DNAtrix Announces Oral Presentation of Positive Overall Survival Data with DNX-2401 in DIPG at the Society for Neuro-oncology (SNO) Annual Meeting

11/18/2021

Presentation of XCELSIOR Observational Protocol for Real World Data Research

11/15/2021

2-THE-TOP Phase 2 Trial Reports Positive Top-Line Results in Newly Diagnosed Glioblastoma

11/15/2021

Novocure Announces 31 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2021 Annual Meeting

11/13/2021

Disparities in access to surgery for glioblastoma multiforme at high-volume Commission on Cancer-accredited hospitals in the United States

11/13/2021

xCures presents the results of their oncology platform at the 2021 SNO Annual Meeting

11/13/2021

Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug

11/11/2021

PNOC Study in Childhood Brain Cancer Enrolls First Patient

Our privacy / cookie policy has changed.
Click HERE to read it!